Phase I bioequivalence trial of extended- versus immediate-release formulation of topiramate, and the effects of food on extended-release topiramate pharmacokinetics in volunteers

Trial Profile

Phase I bioequivalence trial of extended- versus immediate-release formulation of topiramate, and the effects of food on extended-release topiramate pharmacokinetics in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Apr 2016

At a glance

  • Drugs Topiramate (Primary)
  • Indications Epilepsy; Migraine
  • Focus Pharmacokinetics
  • Most Recent Events

    • 21 Apr 2016 Results of pooled analysis from three phase I and two phase III studies assessing the differentiating features of Topiramate (extented release capsules and immediate release) presented at the 68th Annual Meeting of the American Academy of Neurology
    • 06 Dec 2011 Results were presented at the 65th Annual Meeting of the American Epilepsy Society (AES-2011)
    • 26 Sep 2011 Results were presented at the Annual Meeting of the American Neurological Associations (ANA-2011).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top